Subtopic Deep Dive

5-Methylcytosine RNA Modifications
Research Guide

What is 5-Methylcytosine RNA Modifications?

5-Methylcytosine (m5C) RNA modifications involve methylation of cytosine residues in tRNA, rRNA, and mRNA by NSUN2/NOP2 methyltransferases, impacting translation efficiency, stress granule formation, and cancer progression.

m5C modifications accumulate in glioblastoma and bladder cancer, correlating with poor prognosis (Hussain et al., 2013; 243 citations). NSUN2 acts as an oncogene driving tumor growth via m5C on mRNA and tRNAs. Over 10 key papers map m5C profiles using Nanopore sequencing and bisulfite methods.

12
Curated Papers
3
Key Challenges

Why It Matters

m5C writers like NSUN2 promote oncogenesis in glioblastoma and bladder cancer, offering urinary biomarkers for diagnosis (Hussain et al., 2013). Trixl and Lusser (2018; 371 citations) link m5C to translation control in cancer stress responses. Léger et al. (2021; 389 citations) enable direct m5C detection in tumors via Nanopore sequencing, aiding prognostic models.

Key Research Challenges

Mapping m5C in cancer transcriptomes

Low-abundance m5C in mRNA requires sensitive detection beyond rRNA/tRNA hotspots (Trixl and Lusser, 2018). Nanopore direct sequencing detects m5C but struggles with basecalling accuracy in tumors (Léger et al., 2021). Cancer heterogeneity demands single-cell epitranscriptomics.

Linking m5C to oncogenic translation

NSUN2-mediated m5C enhances translation efficiency, but reader proteins remain unidentified (Hussain et al., 2013). Stress granule dynamics in glioblastoma evade standard assays (Amort et al., 2017). Functional validation needs CRISPR-edited cancer models.

Therapeutic targeting of NSUN2

NSUN2 inhibition disrupts m5C in bladder cancer biomarkers, but off-target effects on normal translation persist (Courtney et al., 2019). Dynamic m5C regulation under hypoxia challenges inhibitor design (Trixl and Lusser, 2018). Clinical translation lacks prognostic validation studies.

Essential Papers

1.

RNA sequencing: new technologies and applications in cancer research

Mingye Hong, Shuang Tao, Ling Zhang et al. · 2020 · Journal of Hematology & Oncology · 556 citations

Abstract Over the past few decades, RNA sequencing has significantly progressed, becoming a paramount approach for transcriptome profiling. The revolution from bulk RNA sequencing to single-molecul...

2.

Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain

Thomas Amort, Dietmar Rieder, Alexandra Wille et al. · 2017 · Genome biology · 514 citations

3.

RNA modifications detection by comparative Nanopore direct RNA sequencing

Adrien Léger, Paulo Amaral, Luca Pandolfini et al. · 2021 · Nature Communications · 389 citations

Abstract RNA molecules undergo a vast array of chemical post-transcriptional modifications (PTMs) that can affect their structure and interaction properties. In recent years, a growing number of PT...

4.

The dynamic RNA modification 5‐methylcytosine and its emerging role as an epitranscriptomic mark

Lukas Trixl, Alexandra Lusser · 2018 · Wiley Interdisciplinary Reviews - RNA · 371 citations

It is a well‐known fact that RNA is the target of a plethora of modifications which currently amount to over a hundred. The vast majority of these modifications was observed in the two most abundan...

5.

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

Mengnuo Chen, Chun‐Ming Wong · 2020 · Molecular Cancer · 360 citations

6.

Mapping the epigenetic modifications of DNA and RNA

Lin-Yong Zhao, Jinghui Song, Yibin Liu et al. · 2020 · Protein & Cell · 345 citations

Abstract Over 17 and 160 types of chemical modifications have been identified in DNA and RNA, respectively. The interest in understanding the various biological functions of DNA and RNA modificatio...

7.

RNA modifications: importance in immune cell biology and related diseases

Lian Cui, Rui Ma, Jiangluyi Cai et al. · 2022 · Signal Transduction and Targeted Therapy · 344 citations

Reading Guide

Foundational Papers

Start with Hussain et al. (2013; 243 citations) for core m5C mapping in mammals, then Liu et al. (2014) for co-methylation patterns establishing epitranscriptome regulators.

Recent Advances

Léger et al. (2021; 389 citations) for Nanopore m5C detection; Trixl and Lusser (2018; 371 citations) for cancer-relevant dynamics; Amort et al. (2017; 514 citations) for tissue-specific profiles.

Core Methods

Bisulfite sequencing for total m5C (Hussain 2013); direct Nanopore basecalling (Léger 2021); meRIP for poly(A) RNA (Amort 2017).

How PapersFlow Helps You Research 5-Methylcytosine RNA Modifications

Discover & Search

Research Agent uses searchPapers('5-methylcytosine RNA cancer NSUN2') to retrieve 250+ OpenAlex papers, then citationGraph on Hussain et al. (2013) reveals 243-citation clusters linking m5C to glioblastoma. exaSearch uncovers Nanopore protocols from Léger et al. (2021), while findSimilarPapers expands to bladder cancer biomarkers.

Analyze & Verify

Analysis Agent applies readPaperContent on Amort et al. (2017) to extract mouse brain m5C profiles, then verifyResponse with CoVe cross-checks NSUN2 claims against Trixl and Lusser (2018). runPythonAnalysis processes Nanopore datasets from Léger et al. (2021) with pandas for m5C motif stats, graded by GRADE for evidence strength in cancer contexts.

Synthesize & Write

Synthesis Agent detects gaps in NSUN2-bladder cancer links via contradiction flagging across 10 papers, generating exportMermaid diagrams of m5C writer-reader pathways. Writing Agent uses latexEditText to draft methods sections, latexSyncCitations for Hussain (2013)/Léger (2021), and latexCompile for full review manuscripts.

Use Cases

"Analyze m5C Nanopore data from bladder cancer samples for NSUN2 motifs"

Research Agent → searchPapers('m5C bladder cancer Nanopore') → Analysis Agent → runPythonAnalysis(pandas motif counting on Léger et al. 2021 data) → matplotlib plots of enrichment scores.

"Write LaTeX review on m5C in glioblastoma translation control"

Synthesis Agent → gap detection (NSUN2 stress granules) → Writing Agent → latexEditText(intro) → latexSyncCitations(Hussain 2013, Trixl 2018) → latexCompile → PDF with figure captions.

"Find GitHub repos analyzing m5C seq data from cancer epitranscriptomics papers"

Research Agent → paperExtractUrls(Hussain 2013) → Code Discovery → paperFindGithubRepo → githubRepoInspect(NSUN2 scripts) → runPythonAnalysis(reproduce m5C mapping pipeline).

Automated Workflows

Deep Research workflow scans 50+ m5C papers via searchPapers → citationGraph → structured report on cancer correlations (Hussain 2013 baseline). DeepScan's 7-steps verify NSUN2 oncogene claims with CoVe checkpoints across Léger (2021) datasets. Theorizer generates hypotheses on m5C readers from Trixl/Lusser (2018) patterns.

Frequently Asked Questions

What defines 5-methylcytosine RNA modifications?

m5C methylates cytosine at C5 position in tRNA, rRNA, mRNA by NSUN2/NOP2 enzymes (Hussain et al., 2013).

What methods detect m5C in cancer RNAs?

Nanopore direct sequencing maps m5C without bisulfite conversion (Léger et al., 2021); meRIP-seq profiles poly(A) m5C (Amort et al., 2017).

What are key papers on m5C in epitranscriptomics?

Hussain et al. (2013; 243 citations) characterized mammalian m5C; Trixl and Lusser (2018; 371 citations) reviewed dynamic roles.

What open problems exist in m5C-cancer research?

Unidentified m5C readers in tumors; NSUN2 inhibitor specificity; single-cell m5C mapping in heterogeneous cancers.

Research RNA modifications and cancer with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching 5-Methylcytosine RNA Modifications with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.